Search
for
Sort by
Research 121–150 of 1000+
- Valorization of Punica granatum L. Leaves Extracts as a Source of Bioactive Molecules
- Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being
- Lipid nanocosmeceuticals: a novel approach to skin therapy for anti-aging and skin disorders
- Barrett's esophagus as a premalignant condition; medical and surgical therapeutic management
- Overexpression of mIGF-1 in Keratinocytes Improves Wound Healing and Accelerates Hair Follicle Formation and Cycling in Mice
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Cellular Senescence and Aging in Myotonic Dystrophy
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Cutaneous complications of chemotherapeutic agents
- Targeting nonmelanoma skin cancer using selective photothermolysis with 595 nm pulsed dye laser: Outcomes of 1080 cases
- Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies
- Alopecia With Endocrine Therapies in Patients With Cancer
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- The evolution of primary multimodality treatment in resectable breast cancer
- Investigation on antimicrobial, antioxidant, and anti-cancerous activity of Agaricus bisporus derived β-Glucan against cervical cancer cell line
- Dermatologic Adverse Events from Cancer Treatments
- Dermatological drugs, topical agents, and cosmetics
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Novel agents for the treatment of alopecia
- Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Androgen Receptor Actions Modify Skin Structure and Chemical Carcinogen-induced Skin Cancer Susceptibility in Mice
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Impact of Chemotherapeutic Drug on People living with Cancer